ITCI
Intra-Cellular Therapies Inc
Price:  
127.19 
USD
Volume:  
1,732,955.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI WACC - Weighted Average Cost of Capital

The WACC of Intra-Cellular Therapies Inc (ITCI) is 6.3%.

The Cost of Equity of Intra-Cellular Therapies Inc (ITCI) is 8.90%.
The Cost of Debt of Intra-Cellular Therapies Inc (ITCI) is 5.00%.

Range Selected
Cost of equity 7.00% - 10.80% 8.90%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.4% - 7.2% 6.3%
WACC

ITCI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.69 1.06
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 10.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.4% 7.2%
Selected WACC 6.3%